Once valued at more than $5B, Intarcia Therapeutics sees all of its execs depart and its final shot at FDA denied

The last members of its executive team have moved on, the phone number at its Boston-based HQ has been shut off, and as of earlier …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Once val­ued at more than $5B, Intar­cia Ther­a­peu­tics sees all of its ex­ecs de­part and its fi­nal shot at FDA de­nied